Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds directly to neutrophils, a key immune cell with relevance to various acute diseases/conditions including COVID-19. This platform is ideal for a variety of diseases where treatments are limited or do not exist.
12
next post